Form 4: Abbott Laboratories Executive Reports Stock Transaction
SEC Form 4 Filing
Senior Vice President Philip P. Boudreau reports disposition of Abbott Laboratories shares to cover tax obligations.
Summary
- On February 29, 2024, Philip P. Boudreau, a Senior Vice President at Abbott Laboratories, disposed of 1,738 common shares to cover tax obligations.
- The transaction was executed at a price of $120.05 per share.
- Following the transaction, Boudreau directly owns 39,353 common shares and indirectly owns 353 shares through a Profit Sharing Trust.
Sentiment
Score: 5
Explanation: This is a neutral regulatory filing detailing a routine stock transaction by an executive. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a routine sale of shares by an executive for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 02/29/2024 | Date of stock transaction |
| 03/01/2024 | Balance in the Abbott Laboratories Stock Retirement Trust |
| 03/04/2024 | Date of signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.